Pharmacodynamics of progesterone women, this effect being the result of suppression of the mid-cycle surge in gonadotropin secretion, is 300 mg/day. However, this figure is based on limited clinical data. Conversely, treatment with a high dosage of oral progesterone of 100 mg four times per day (or 400 mg/day total) in men for 10 days that resulted in approximately mid-luteal phase levels of progesterone (7.9–9.4 ng/mL; measured by ) did not cause any change in testosterone levels, suggesting that progesterone has little or no antigonadotropic effect in males at typical clinical dosages. In addition, a study found that administration of 1,000 mg/day oral
Menstrual synchrony of the thawed axillary pad under their noses daily. The researchers concluded that odorless compounds collected from women during the late follicular phase of their menstrual cycles triggered hormonal events that shortened the menstrual cycles of the recipient women, and that odorless compounds collected from women during the time of ovulation triggered a hormonal event in the recipient women that lengthened their menstrual cycles. Stern and McClintock concluded that these findings "proved the existence of human pheromones" as well as illustrated manipulation of the human menstrual cycle. Researchers pointed out several flaws in their study. Whitten's main critiques was with